KH Med: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
KH Med
Largest movements
- Cash +€102,488
up €102,488 (+368.5%), from €27,814 to €130,302
mainly Net result for the year (+€90,357) and Tax, wage and social debts (+€24,466)
- Receivables within one year +€4,165
up €4,165 (+12.9%), from €32,273 to €36,438
- Profit (loss) carried forward +€90,357
up €90,357 (+187.1%), from €48,289 to €138,647
- Tax, wage and social debts +€24,466
up €24,466 (+196.7%), from €12,438 to €36,904
- Other debts -€13,456
down €13,456 (-26.0%), from €51,787 to €38,331
- Trade debts +€3,404
up €3,404 (+317.0%), from €1,074 to €4,478
- Gross operating margin +€62,643
up €62,643 (+97.4%), from €64,315 to €126,958
- Taxes +€12,027
up €12,027 (+96.7%), from €12,438 to €24,466
- Depreciation +€8,476
up €8,476 (+244.4%), from €3,468 to €11,944
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €115,639 | €220,360 | +€104,721 | +90.6% |
| Fixed assets | 21/28 | €53,775 | €51,703 | -€2,071 | -3.9% |
| Tangible fixed assets | 22/27 | €53,775 | €51,703 | -€2,071 | -3.9% |
| Furniture and vehicles | 24 | €53,775 | €47,244 | -€6,531 | -12.1% |
| Other tangible fixed assets | 26 | - | €4,459 | +€4,459 | |
| Current assets | 29/58 | €61,864 | €168,656 | +€106,793 | +172.6% |
| Amounts receivable within one year | 40/41 | €32,273 | €36,438 | +€4,165 | +12.9% |
| Other amounts receivable | 41 | €32,273 | €36,438 | +€4,165 | +12.9% |
| Cash at bank and in hand | 54/58 | €27,814 | €130,302 | +€102,488 | +368.5% |
| Deferred charges and accrued income | 490/1 | €1,776 | €1,916 | +€140 | +7.9% |
| Total equity and liabilities | 10/49 | €115,639 | €220,360 | +€104,721 | +90.6% |
| Equity | 10/15 | €50,289 | €140,647 | +€90,357 | +179.7% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €48,289 | €138,647 | +€90,357 | +187.1% |
| Amounts payable | 17/49 | €65,349 | €79,713 | +€14,364 | +22.0% |
| Amounts payable within one year | 42/48 | €65,299 | €79,713 | +€14,414 | +22.1% |
| Trade debts | 44 | €1,074 | €4,478 | +€3,404 | +317.0% |
| Suppliers | 440/4 | €1,074 | €4,478 | +€3,404 | +317.0% |
| Taxes, remuneration and social security | 45 | €12,438 | €36,904 | +€24,466 | +196.7% |
| Taxes | 450/3 | €12,438 | €36,904 | +€24,466 | +196.7% |
| Other amounts payable | 47/48 | €51,787 | €38,331 | -€13,456 | -26.0% |
| Accrued charges and deferred income | 492/3 | €50 | - | -€50 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,468 | €11,944 | +€8,476 | +244.4% |
| Other operating charges | 640/8 | €87 | €101 | +€15 | +17.0% |
| Gross operating margin | 9900 | €64,315 | €126,958 | +€62,643 | +97.4% |
| Operating profit (loss) | 9901 | €60,760 | €114,913 | +€54,153 | +89.1% |
| Financial income | 75/76B | €6 | €0 | -€6 | -98.2% |
| Recurring financial income | 75 | €6 | €0 | -€6 | -98.2% |
| Financial charges | 65/66B | €39 | €90 | +€52 | +133.8% |
| Recurring financial charges | 65 | €39 | €90 | +€52 | +133.8% |
| Profit (loss) for the period before taxes | 9903 | €60,728 | €114,823 | +€54,095 | +89.1% |
| Income taxes | 67/77 | €12,438 | €24,466 | +€12,027 | +96.7% |
| Profit (loss) for the period | 9904 | €48,289 | €90,357 | +€42,068 | +87.1% |
| Profit (loss) for the period to be appropriated | 9905 | €48,289 | €90,357 | +€42,068 | +87.1% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.